换一批
换一批Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
第一作者：
R,Wenzel
第一单位：
Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Old City Hall, 1001 East Broad Street, 4th Floor Suite 405, P.O. Box 980663, Richmond, VA 23298-0663, USA. rwenzel@hsc.vcu.edu
作者：
主题词
两性霉素B(Amphotericin B);抗真菌药(Antifungal Agents);曲霉菌病(Aspergillosis);费用节省(Cost Savings);费用效益分析(Cost-Benefit Analysis);脱氧胆酸(Deoxycholic Acid);复方合剂(Drug Combinations);卫生保健费用(Health Care Costs);人类(Humans);免疫减弱宿主(Immunocompromised Host);嘧啶类(Pyrimidines);三唑类(Triazoles)
DOI
10.1093/jac/dkh535
PMID
15728146
发布时间
2022-04-08
- 浏览37
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
